| Literature DB >> 27840151 |
Hugh Ip1, Tariq Sethi2.
Abstract
CD98 is implicated in a large number of cancers. CD98 regulates amino acid transport and integrin signaling, which are key drivers in tumor progression. The light chain in the CD98 heterodimer functions as an amino acid exchanger. Alongside the light chain, the heavy chain forms a heterocomplex at the plasma membrane to mediate signaling pathways. In this article, we review various approaches to blocking CD98 activity, which may lead to novel opportunities in cancer therapeutics.Entities:
Keywords: Amino acid transport; CD98;Cancer; Integrins; Signalling
Mesh:
Substances:
Year: 2016 PMID: 27840151 DOI: 10.1016/j.biocel.2016.11.005
Source DB: PubMed Journal: Int J Biochem Cell Biol ISSN: 1357-2725 Impact factor: 5.085